Krisztina Eva Sajosi’s journey from BIA-ALCL diagnosis to international advocacy is both powerful and deeply personal. Today we honor her resilience and commitment to raising global awareness about the hidden risks of breast implants, and her tireless efforts to ensure no woman faces this alone or uninformed.

The FDA plays a major role in deciding which medical devices are safe, but who ensures that patient voices are heard in those decisions? BISA’s own Maria Gmitro has been appointed as a Consumer Representative for the FDA, bringing real-world patient perspectives to the table. Read on to find out why this is a major win for patient advocacy!

On February 6, 2025, the FDA provided updates on the safety and effectiveness of breast implants. BISA provides a brief summary and why this info is crucial for the public.